Next Financial Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $258K | Sell |
3,619
-1,080
| -23% | -$77K | 0.02% | 798 |
|
|
2021
Q3 | $352K | Sell |
4,699
-10
| -0.2% | -$749 | 0.03% | 602 |
|
|
2021
Q2 | $364K | Sell |
4,709
-18
| -0.4% | -$1.39K | 0.03% | 591 |
|
|
2021
Q1 | $349K | Sell |
4,727
-434
| -8% | -$32K | 0.03% | 556 |
|
|
2020
Q4 | $362K | Buy |
5,161
+206
| +4% | +$14.4K | 0.03% | 488 |
|
|
2020
Q3 | $281K | Buy |
4,955
+108
| +2% | +$6.13K | 0.03% | 519 |
|
|
2020
Q2 | $282K | Buy |
4,847
+640
| +15% | +$37.2K | 0.03% | 438 |
|
|
2020
Q1 | $196K | Buy |
4,207
+4
| +0.1% | +$186 | 0.03% | 535 |
|
|
2019
Q4 | $235K | Buy |
4,203
+1,465
| +54% | +$81.9K | 0.02% | 639 |
|
|
2019
Q3 | $130K | Hold |
2,738
| – | – | 0.01% | 825 |
|
|
2019
Q2 | $147K | Buy |
2,738
+338
| +14% | +$18.1K | 0.02% | 769 |
|
|
2019
Q1 | $132K | Sell |
2,400
-1,035
| -30% | -$56.9K | 0.03% | 465 |
|
|
2018
Q4 | $162K | Buy |
3,435
+2,035
| +145% | +$96K | 0.03% | 442 |
|
|
2018
Q3 | $83K | Buy |
+1,400
| New | +$83K | 0.04% | 409 |
|
|
2017
Q4 | – | Sell |
-1,350
| Closed | -$67K | – | 1050 |
|
|
2017
Q3 | $67K | Buy |
1,350
+900
| +200% | +$44.7K | 0.02% | 618 |
|
|
2017
Q2 | $21K | Buy |
450
+250
| +125% | +$11.7K | 0.01% | 1059 |
|
|
2017
Q1 | $9K | Hold |
200
| – | – | ﹤0.01% | 1323 |
|
|
2016
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 1752 |
|
|
2016
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 1766 |
|
|
2016
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 1331 |
|
|
2016
Q1 | $7K | Sell |
200
-100
| -33% | -$3.5K | ﹤0.01% | 1287 |
|
|
2015
Q4 | $15K | Hold |
300
| – | – | 0.01% | 1040 |
|
|
2015
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 1117 |
|
|
2015
Q2 | $17K | Hold |
300
| – | – | 0.01% | 1064 |
|
|
2015
Q1 | $16K | Hold |
300
| – | – | 0.01% | 1082 |
|
|
2014
Q4 | $15K | Buy |
300
+100
| +50% | +$5K | 0.01% | 1101 |
|
|
2014
Q3 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 1808 |
|